Aardvark Therapeutics Inc. Common Stock

AARD | NASDAQ

$5.57

+$0.19 (+3.53%)

At close: Sep 21, 2026, 4:00 PM ET

$5.56

-$0.01 (-0.18%)

After-hours: Sep 21, 2026, 7:54 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
PE Ratio	-4.97	-15.06	-42.09	-22.71
PEG Ratio	-0.03	-0.08	0.91	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	2.69	-5.68	-8.79	-10.96
P/FCF Ratio	-5.28	-17.06	-52.54	-29.02
P/OCF Ratio	-5.29	-17.17	-52.54	-29.02
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	-0.01	0	-0.01
Quick Ratio	10.61	15.05	7.50	27.72
Current Ratio	10.61	15.05	7.50	27.72
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a
Return on Equity	-54.01%	37.68%	20.71%	48.58%
Return on Assets	-49.15%	-26.56%	-68.41%	-80.95%
Return on Invested Capital	-58.58%	-31.25%	-80.02%	-69.87%
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a